Safety and Efficacy of ventilation delivered by a full automated mode (Intellivent-ASV): a randomized controlled study

Émilie Bialais(Cliniques Universitaires Saint-Luc), Philippe Hantson, Laurence Vignaux, Xavier Wittebole(Cliniques Universitaires Saint-Luc), T Sottiaux(Clinique Saint-Joseph), Jörg Meyer, Marc Wysocki, Jean Roeseler(University Hospital of Geneva), Grégory Reychler(Cliniques Universitaires Saint-Luc), Dominik Novotni, Pierre‐François Laterre(Cliniques Universitaires Saint-Luc)
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))
January 1, 2013
Cited by 0

Related Papers

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
|New England Journal of Medicine|2001|6.1k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
|JAMA|2020|1k
Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
|New England Journal of Medicine|2005|890
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
|JAMA|2013|797